30.07.2010 • News

Wacker Ends Q2 2010 with New Sales Record

Wacker Chemie ended Q2 2010 with a new sales record, primarily thanks to much higher sales volumes. Q2 2010 sales climbed 30% to €1,202.0 million (Q2 2009: €925.5 million). Growth was additionally driven by the stronger US dollar. In contrast, lower prices slowed the sales increase to some extent.

Wacker also posted clear earnings gains compared to both a year ago and Q1 2010. Earnings before interest, taxes, depreciation and amortization (Ebitda) in Q2 climbed to €308.6 million (Q2 2009: €170.1 million) up over 81% on the prior year, Ebitda rose at more than double the rate of sales.

Company

Logo:

Wacker Chemie

Hanns-Seidel-Platz 4
81737 Munich
Germany

Company contact







Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.